Abstract
Lipopolysaccharides (LPS) are involved in endotoxin-mediated heart failure and chronic cardiac myopathies. We have shown previously that lipopolysaccharides (LPS) directly affect murine-derived HL-1 cardiac myocyte function via TLR-4 by inhibiting Ca2+ oscillations, by decreasing intracellular Ca2+ concentration, Ca2+i, and by impairing pacemaker Bfunny current, If, (Wondergem et al. Am. J. Physiol. Cell Physiol. 299:C665-71, 2010). Here we report LPS effects on human, induced pluripotent stem cell (hiPSC)-derived cardiomyocytes (iCellA Cardiomyocytes). In marked contrast to the inhibitory effects of LPS on HL-1 cells, LPS (S. enteriditis or E. coli) in a dose-dependent manner (0.01- 1.0 2g/ml) increased the rate of Ca2+ oscillations and the Ca2+i in iCell Cardiomyocytes. Ca2+-free external solution abolished this stimulation by LPS. Ultra-pure LPS (E. coli), which is considered a TLR-4 specific agonist, exerted identical effects as the impure LPS. Prior addition of the monoclonalantibody blocking peptide, MAb hTLR4, attenuated the effect of ultra-pure LPS. Pam3Csk, a TLR-2 agonist, had no effect on Ca2+ oscillations or Ca2+i. iCell Cardiomyocytes also expressed TLR-4 as determined by flow cytometry. We conclude that LPS, acutely applied to human iCell Cardiomyocytes, results in TLR-4-dependent increases in Ca2+ oscillations and Ca2+i, which are consistent with a hyperdynamic response. This is in marked contrast to the hypodynamic response that we reported previously for acute effects of LPS on murine cardiomyocytes.
Users
Please
log in to take part in the discussion (add own reviews or comments).